Exploring Key Insights of the Generic Musculoskeletal Disorders Drugs Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the generic musculoskeletal disorders drugs market grown in recent years?
In recent times, the market size of generic drugs for musculoskeletal disorders has seen significant growth. The numbers project that it will rise from $0.06 billion in 2024 to $0.06 billion in 2025, with a remarkable compound annual growth rate (CAGR) of 6.7%. Various elements have contributed to the growth in the historic period, including the incidence of musculoskeletal disorders, the regulatory environment, the enhancement of healthcare infrastructure, patient knowledge and education, as well as economic factors.
How is the generic musculoskeletal disorders drugs market size expected to evolve during the forecast period?
Over the next few years, the generic musculoskeletal disorders drugs market is predicted to experience robust growth. It is anticipated to surge to $0.08 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. A number of factors will contribute to this growth during the forecast period, including population expansion and aging, the rise of emerging markets, the development of precision medicine and personalized therapies, changes in healthcare policy, and global health trends. Key trends for the projection period incorporate technological advancements in treatment procedures, government programs and healthcare policies, a heightened focus on alternative pain management strategies, a growing acceptance of biosimilars, and progress in the development of generic drugs.
Get your generic musculoskeletal disorders drugs market report here!
Which key drivers are propelling the generic musculoskeletal disorders drugs market’s growth?
The rise in instances of arthritis is anticipated to significantly boost the development of the generic musculoskeletal disorders drugs market. Arthritis, which is characterized by joint inflammation and sensitivity, also causes symptoms like joint pain and stiffness. Drugs for generic musculoskeletal disorders are very effective in easing muscular discomfort and treating spasms in arthritis sufferers. For example, as per Versus Arthritis, a charity organization in the UK, data from March 2022 showed that roughly 10 million individuals in the UK suffer from osteoarthritis, with 5.4 million and 3.2 million having knee and hip OA respectively. Additionally, around 450,000 are diagnosed with rheumatoid arthritis while approximately 190,000 have psoriatic arthritis. All these cases add up and result in over 20 million people battling musculoskeletal disorders and over 30 million prescriptions being written for these issues at a cost of roughly £139 million in 2022-2023. Thus, the surge in arthritis diagnosis is spurring the growth of the generic musculoskeletal disorders drugs market.
What are the market segments in the generic musculoskeletal disorders drugs industry?
The generic musculoskeletal disorders drugs market covered in this report is segmented –
1) By Treatment Type: Medication, Therapy, Surgery, Other Treatment Types
2) By Disorder Type: Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy
Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics
2) By Therapy: Physical Therapy, Occupational Therapy, Chiropractic Treatment, Massage Therapy
3) By Surgery: Joint Replacement Surgery, Arthroscopy, Spinal Surgery, Fusion Surgery
4) By Other Treatment Types: Lifestyle Modifications, Alternative Therapies, Assistive Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9433&type=smp
Which leading companies are shaping the growth of the generic musculoskeletal disorders drugs market?
Major companies operating in the generic musculoskeletal disorders drugs market include Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Flexion Therapeutics Inc.
What key trends are currently impacting the generic musculoskeletal disorders drugs market’s development?
The surge in strategic alliances is a prominent trend observed in the generic drugs market for musculoskeletal disorders. Numerous companies within this market are embracing partnerships to fortify their market stance. A case in point is the collaboration between Mitsubishi Tanabe Pharma Corporation, a pharmaceutical firm from Japan, and Eli Lilly and Company, a pharmaceutical organization based in the United States, in July 2022. This alliance has equipped both entities to expand their product offerings and provide patients with effective remedies for diseases like diabetes, among others. In another instance, Pfizer Inc., a US-based pharmaceutical and biotech company, joined forces with Alex Therapeutics, a digital therapeutics firm from Sweden, in February 2022. This fresh partnership aims to provide patients with digitally therapeutic solutions that are evidence-based, clinically proven, and customised.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9433
Which geographic areas are influencing the growth of the generic musculoskeletal disorders drugs market?
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2024. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Metabolic Disorders Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Musculoskeletal Disorders Drugs Global Market Report 2022
Gastrointestinal Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
